European Journal of Cancer
Volume 46, Issue 2 , Pages 340-347 , January 2010

Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies

  • Shivaani Kummar

      Affiliations

    • Center for Cancer Research, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, USA
    • Corresponding Author InformationCorresponding author: Tel.: +1 301 435 5402; fax: +1 301 402 0172.
    • Both authors contributed equally to the manuscript.
    • ,
  • Martin E. Gutierrez

      Affiliations

    • Center for Cancer Research, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, USA
    • Both authors contributed equally to the manuscript.
    • ,
  • Erin R. Gardner

      Affiliations

    • Science Applications International Corporation-Frederick, Inc., National Cancer Institute-Frederick, Frederick, MD 21702, USA
    • ,
  • Xiaohong Chen

      Affiliations

    • Center for Cancer Research, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, USA
    • ,
  • William D. Figg

      Affiliations

    • Center for Cancer Research, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, USA
    • ,
  • Maria Zajac-Kaye

      Affiliations

    • Center for Cancer Research, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, USA
    • ,
  • Min Chen

      Affiliations

    • Center for Cancer Research, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, USA
    • ,
  • Seth M. Steinberg

      Affiliations

    • Center for Cancer Research, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, USA
    • ,
  • Christine A. Muir

      Affiliations

    • Center for Cancer Research, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, USA
    • ,
  • Mary Ann Yancey

      Affiliations

    • Center for Cancer Research, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, USA
    • ,
  • Yvonne R. Horneffer

      Affiliations

    • Center for Cancer Research, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, USA
    • ,
  • Lamin Juwara

      Affiliations

    • Science Applications International Corporation-Frederick, Inc., National Cancer Institute-Frederick, Frederick, MD 21702, USA
    • ,
  • Giovanni Melillo

      Affiliations

    • Science Applications International Corporation-Frederick, Inc., National Cancer Institute-Frederick, Frederick, MD 21702, USA
    • ,
  • S. Percy Ivy

      Affiliations

    • Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA
    • ,
  • Maria Merino

      Affiliations

    • Center for Cancer Research, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, USA
    • ,
  • Len Neckers

      Affiliations

    • Center for Cancer Research, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, USA
    • ,
  • Patricia S. Steeg

      Affiliations

    • Center for Cancer Research, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, USA
    • ,
  • Barbara A. Conley

      Affiliations

    • Center for Cancer Research, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, USA
    • Present address: Department of Medicine, Michigan State University, East Lansing, MI 48824, USA.
    • ,
  • Giuseppe Giaccone

      Affiliations

    • Center for Cancer Research, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, USA
    • ,
  • James H. Doroshow

      Affiliations

    • Center for Cancer Research, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, USA
    • Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA
    • ,
  • Anthony J. Murgo

      Affiliations

    • Center for Cancer Research, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, USA
    • Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA

Received 13 May 2009 ,Revised 20 October 2009 ,Accepted 29 October 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This paper was written with support from the Division of Cancer Treatment and Diagnosis and the Center for Cancer Research of the National Cancer Institute. This project has been funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. This work was supported by the Intramural Research Programme of the NIH, National Cancer Institute, Center for Cancer Research.

PII: S0959-8049(09)00813-2

doi: 10.1016/j.ejca.2009.10.026

European Journal of Cancer
Volume 46, Issue 2 , Pages 340-347 , January 2010

Article Tools

* Image Usage & Resolution